Skip to content

Alerting on adverse Drug reactions: Falls prevention Improvement through developing a Computerized clinical support system: Effectiveness of Individualized medicaTion withdrawal

Alerting on adverse Drug reactions: Falls prevention Improvement through developing a Computerized clinical support system: Effectiveness of Individualized medicaTion withdrawal - ADFICE_IT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51926
Enrollment
856
Registered
2021-09-27
Start date
2022-07-07
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vallen met letsel falls with injury Injurious falls

Interventions

The concurrent use of a CDSS and a patient portal for personalized FRID withdrawal.

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
65 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. 65 years or older; 2. history of a fall (in the past year); 3. a Mini-Mental State Examination Score of 21 points or higher or a Montreal Cognitive Assessment - Dutch score of 16 points or higher; 4. willingness to sign informed consent; 5. Use of at least one FRID; and 6. sufficient command of the Dutch language.

Exclusion criteria

Exclusion criteria: 1. Life expectancy of less than one year; 2. Immobility (bedridden, e.g. inability to walk short distances with assistance of a walking aid)

Design outcomes

Primary

MeasureTime frame
The main study parameter is the time to the first injurious fall.

Secondary

MeasureTime frame
Secondary outcome measures are: number of injurious falls, time to first fall resulting in minor injuries, number of falls resulting in minor injuries, time to first fall, total number of falls, (health-related) quality of life, and patient-reported outcomes. We will also conduct a process evaluation to evaluate the implementation of the CDSS and patient portal and we will investigate the cost-effectiveness of the CDSS and patient portal

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)